JNJ Reports Nearly 3.5 Years Median Survival In Lung Cancer Study
JNJ Reports Nearly 3.5 Years Median Survival In Lung Cancer Study Stocktwits
Covered in this story
Dalsna Finance is currently tracking 46 stories mentioning Johnson & Johnson, the earliest published 29 May 2026.
Summary aggregated from Stocktwits's public RSS feed. The full reporting belongs to Stocktwits — please read it on their site.